Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Tax-Loss Selling Drives Down Junior Stock Prices

Vista Gold Corp. (VGZ:NYSE.MKT; VGZ:TSX, US$0.59) has published an updated prefeasibility study (PFS) on its Mt Todd project in the Northern Territories in Australia, the largest undeveloped gold project in that country. The revisions to the old PFS include updating bo...
Streetwise Reports | November 28, 2019 |

FDA Grants Breakthrough Status to Biopharma's Lead Candidate for Liver Disease

The California firm's most advanced asset is advancing through Phase 2b, according to a ROTH Capital Partners report. In a Feb. 19 research note, analyst Yasmeen Rahimi reported that CymaBay Therapeutics Inc. (CBAY:NASDAQ) is having a strong Q1/19 with respect to cont...
Streetwise Reports | February 26, 2019 |

Ra Pharmaceuticals Shares Up 100% Following $2.1 Billion Takeover Bid

Shares of Ra Pharmaceuticals doubled today after the firm announced that it will be acquired by Belgian firm UCB for $48 per share in an all cash deal. Prior to the market open this morning Ra Pharmaceuticals Inc. (RARX:NASDAQ) and Brussels-based UCB (UCB:Euronext)...
Streetwise Reports | October 11, 2019 |

Apellis Pharma Shares Rise 20% on Positive Top-line Data in Phase 3 PNH Trial

Shares of Apellis Pharmaceuticals opened 35% higher and established a new 52-week intraday high price today after the company announced positive top-line results from its Phase 3 head-to-head study of Pegcetacoplan (APL-2) versus Eculizumab in patients with Paroxysmal Nocturna...
Streetwise Reports | January 8, 2020 |

Buzz on the Bullboards: Where volatility meets opportunity

It has been a wild ride for markets on Bay Street and Wall Street this week. Some indices hit lows not seen in nearly a year after a concerning inflation report, only to bounce back the next day. It is reporting season for many companies, and Stockhouse users seem...
Jonathon Brown | February 15, 2024 |

Will Democrats fire back with second stimulus?

Data revealed last week showed a job market that's careening down a steep street with no breaks. Yet investors shrugged off concerns and the stock market actually ended the week up 1.5% due to that rockin' Monday on the first day of the month. That's because there...
Jon D. Markman | October 28, 2012 |

New electric industrial heat technology to reduce greenhouse gas emissions

The following is a transcription of the above video, and The Market Online has edited it for clarity . Acceleware Ltd. (TSXV:AXE) is an advanced electromagnetic heating company with highly scalable EM solutions for large industrial applications. CEO Geoff Clark joi...
Coreena Robertson | October 30, 2024 |

NexOptic: delivers AI solutions that reduce bandwidth

Our next company puts humans first, creating quality artificial intelligence solutions that offer patented solutions for energy savings, data compression and more. In May 2019, AlIIS was born. A machine-learning AI that is giving new life to imaging platforms by giving ac...
Brieanna McCutcheon | March 8, 2023 |

Helping Cure Opioid Addiction with the Billion-Dollar Ibogaine Market

Psychedelics are the real deal. They can help people in need, change the world, and make a lot of money, all at the same time. The severity of the opioid crisis has been well documented and needs a solution: One that is able to reduce the both the strain on thousands impa...
Omri Wallach | January 28, 2020 |

Subliminal Capitulation

Looking back at the events of last week, the S&P 500 finally took out the October highs at 2,941 intraday, making the 2018 bear market one of the shortest on record at 93 days (Sept. 21–Dec. 24). You will recall that I wrote in early January that the action of the Santa C...
Streetwise Reports | May 8, 2019 |
1 2 3 4 5 6 7 8 9 10 ...